FDA Investigator John S Hartford

John S Hartford has conducted inspections on 196 sites in 3 countries as of 11 May 2012. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
196
Last Inspection Date:
11 May 2012
Investigator Role:
FDA Investigator
Redica ID:
100007294
Countries of Inspections:
United States of America, India, China
FDA Investigators that have inspected at least one site in common with John S Hartford:
Aaron L Morris, Abby E Pelletier, Alan P Kurtzberg, Alan R Condon, Alanna L Mussawwir Bias, Alice C Silva, Allen F Hall, Alois P Provost, Alysia M Salonia, Amanda E Lewin, PhD, Amber G Wardwell, Amy C Jordan, Andrew J Seaborn, Andrew M Barlow, Angela E Glenn, Angela J Davis, Ann Marie Montemurro, Ann Marie Schofield, Annet R Rajan, Anthony N Onianwa, Anthony W Thomas, Arie C Menachem, Asia D Clark, Barbara J Maulfair, Bo Chi, PhD, Bonita S Chester, Bradford L Swanson, Brandy L Couillard, Brenda W Uratani, PhD, Brenna L Macdowell, Burnell M Henry, Camerson E Moore, Candace Y Gomez Broughton, Carl A Huffman, III, Carolyn Yong, PhD, Constance Desimone, Courtney N Long, Cynthia A Harris, MD, RN, Cynthia Jim, CSO, Danielle S Pearson, Darin S Wiegers, David P Vanhouten, David R Heiar, Dawn M Braswell, Dien N Nguyen, Donald C Obenhuber, PhD, Douglas A Campbell, Douglas S Joslin, Dr. Robert C Horan, MD, Edmund F Mrak, Jr, Elizabeth B Griffin, Ellen P Madigan, Eric M Mueller, PharmD, Felix Maldonado, Gajendiran Mahadevan, PhD, Garry H Stewart, Gary J Hagan, Gena M Mckahan, Gene D Arcy, Gerard D Difiore, Jacek Cieslak, PhD, Jacqueline Mdiaz Albertini, Jai P Singh, James W Whitney, Jamie S Mathews, Janis S Gallagher, Jason A Rossi, Joel R Merriman, John A Sciacchitano, John J Thibodeau, John L Zaccone, John P Mistler, John P Shelton, John R Carlson, John Stansberry, PhD, Jonah S Ufferfilge, Jonathan B Lewis, Jonathan G Matrisciano, Jose A Torres, Joyce A Kellett, Justine M Corson, Kalavati Suvarna, PhD, Kara A Scheibner, PhD, Karen N Archdeacon, Katarzyna Plona, Kathleen E Mcafoose, Kathleen M Curry, Kathryn A Krentz, Kent A Conforti, Kevin A Gonzalez, Kirtida Patel, L Norwood, Laurel A Beer, Laurie B Frazier, Laurie Graham, LCDR Debra Emerson, Leo B Zadecky, Lewis K Antwi, Lorayne A Mcguinness, Lori A Holmquist, Louis Christy, M Pedgen, Marc R Dickens, Margaret M Sands, Mariza M Jafary, Marlene G Swider, Marlene L Davis, Martin J Guardia, Mary E Baker Brown, Mary Jeanet Mcgarry, Matthew C Watson, Megan A Haggerty, Michael J Leal, Michael P Anthony, Michelle M Noe Varga, Michelle Yclark Stuart, Mihaly S Ligmond, Mikayla K Deardorff, Mohsen Rajabi Abhari, FDA, Nancy L Neiger, Nicholas E Stuhr, Nicholas J Scire, Nichole B Murphy, Nisha C Patel, Obinna R Echeozo, Omotunde O Osunsanmi, Pamela L Ogonowski, Pankaj H Amin, Paraluman S Leonin, Patricia F Hughes, PhD, Paul P Geraci, Paula M Laplant, Pete Amin (Pankaj), Philip Kreiter, Prabhu P Raju, Priscilla M Pastrana, Ramon E Martinez, Ranjani Prabhakara, Rashmi Rawat, PhD, Rebecca A Coleman, Richard F Hapke, Richard H Penta, Robert E Teel, Robert J Martin, Robert Jennings, Roger F Zabinski, Rosa M Santiago, Rose Ashley, Ruben C Ayala, PharmD, Rupa Pradhan, Saleem A Akhtar, Sandra P White, Scott R Nichols, PhD, Sean R Marcsisin, Sean R Moynihan, MPH, Sharon Rhew, Sherri N Rohlf, MD, Sherry M Nisson, Simone E Pitts, Slater K Bartlett, Sripal R Mada, PhD, Stacey S Degarmo, Stephen C Smith, Susanne M Richardson, MS RAC, Svetlana A Shestopal, Sylvia A Craven, Tania K Mercado, Tanya R Syffrard, Terrig Thomas, PhD, Thomas H Jenkins, Thomas O Morgan, Thomas Siebertz, Troy R Petrillo, Victor J Gangi, Victoria M Daddeo, Vijaya L Simhadri, Wayne E Seifert, Wayne T Smith, Willis I Cobb Jr

John S Hartford's Documents

Publish Date Document Type Title
August, 2006 FDA 483 Arzol Chemical Company - Form 483, 2006-08-09
June, 2003 EIR Rhode Island Blood Center, A Division of New York Blood Center, Inc. - EIR, 2003-06-19
June, 2012 FDA 483 Advantageous MD Llc - Form 483, 2012-06-12
February, 2011 FDA 483 Allendale IRB - Form 483, 2011-02-23
October, 2003 FDA 483 Lonza Biologics, Inc. - Form 483, 2003-10-29
October, 2002 FDA 483 Ever Better Eating, Inc. - Form 483, 2002-10-22
October, 2003 FDA 483 Response Lonza Biologics, Inc. - Form 483R, 2003-11-26
October, 2003 EIR Lonza Biologics, Inc. - EIR, 2003-10-29

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more